Janux Therapeutics increases CEO base salary to $500k, bonus target to 50%

Janux Therapeutics, Inc.

CEO David Campbell's annual base salary increased from $424,408 to $500,000 effective July 15, 2021.
Annual target performance bonus percentage increased from 40% to 50%, retroactive to beginning of 2021.
Changes approved by Board of Directors upon Compensation Committee recommendation.

item 5.02

Janux Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-21-217455

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.